Literature DB >> 21468372

Minimal clinically important differences in nasal peak inspiratory flow.

Daniel Timperley1, Aviva Srubisky, Nicholas Stow, George N Marcells, Richard J Harvey.   

Abstract

INTRODUCTION: Acoustic Rhinometry, Rhinomanometry, Nasal Spirometry and Nasal Peak Inspiratory flow (NPIF) all measure subtly different constructs of nasal function. All have limitations but NPIF is simple and quick to integrate into clinical practice. The minimum clinically important difference (MCID) for an outcome measure is an estimate of the smallest change that is experienced by a patient or group as being significant. Studies, particularly with large samples, may generate results that while statistically significant, have limited clinical effect. Defining MCID allows an assessment of the clinical impact of an intervention. This study defines the MCID for NPIF.
METHODS: Prospective study of patients from a tertiary clinic undergoing open septorhinoplasty. Nasal obstruction scores and NPIF were recorded before and after surgery. Global function and nasal obstruction scores were used to assess subjective change. Statistical based and patient anchored techniques were used to define MCID.
RESULTS: 51 patients with a mean age 36 +- 13 yrs (75% female) were recruited. All had open rhinoplasty, septal reconstruction, spreader grafts and turbinate reduction. Baseline NPIF was 101 +- 35 L/min. The statistically derived MCID (half standard deviation) was 18 L/min, the patient anchored approaches were 20 L/min and 20-25 L/min. DISCUSSION: Although NPIF is effort dependant with the potential for poor test-retest reliability, it is simple, quick and a reliable technique can be quickly learnt. An MCID of 20L/min is recommended when NPIF is used as an outcome tool. Understanding the MCID is critical for assessing the impact of nasal surgery.

Entities:  

Mesh:

Year:  2011        PMID: 21468372     DOI: 10.4193/Rhino10.097

Source DB:  PubMed          Journal:  Rhinology        ISSN: 0300-0729            Impact factor:   3.681


  7 in total

1.  Cosmetic and Functional Outcomes of Septorhinoplasty.

Authors:  V Sasindran; B Harikrishan; N Mathew
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2019-11-05

2.  Peak Nasal Inspiratory Flow as an Objective Measure of Nasal Obstruction and Functional Septorhinoplasty Outcomes.

Authors:  Jennifer C Fuller; Carly H Bernstein; Patricia A Levesque; Robin W Lindsay
Journal:  JAMA Facial Plast Surg       Date:  2018-03-01       Impact factor: 4.611

3.  Accuracy of peak nasal flow to determine nasal obstruction in patients with allergic rhinitis.

Authors:  Gardênia Maria Martins de Oliveira; Marco Aurélio de Valois Correia Júnior; Emilia Chagas Costa; Georgia Véras de Araújo Gueiros Lira; José Ângelo Rizzo; Steve Hunter; Nádia Gaua; Emanuel Sávio Cavalcanti Sarinho
Journal:  Acta Otorhinolaryngol Ital       Date:  2022-04       Impact factor: 2.618

4.  Analysis of Patient-Perceived Nasal Appearance Evaluations Following Functional Septorhinoplasty With Spreader Graft Placement.

Authors:  Jennifer C Fuller; Patricia A Levesque; Robin W Lindsay
Journal:  JAMA Facial Plast Surg       Date:  2019-07-01       Impact factor: 4.611

5.  Unilateral and Bilateral PNIF in Quality Control of Nasal Septal Surgery.

Authors:  Liv Kari Døsen; Knut Kvinnesland; Magnus TarAngen; Olga Shiryaeva; Caryl Gay; Rolf Haye
Journal:  Int J Otolaryngol       Date:  2018-10-16

6.  Association Between Mental Health Status and Patient Satisfaction With the Functional Outcomes of Rhinoplasty.

Authors:  Erika Strazdins; Yu Feng Nie; Raziqah Ramli; Tom Palesy; Jenna M Christensen; Raquel Alvarado; George N Marcells; Richard J Harvey
Journal:  JAMA Facial Plast Surg       Date:  2018-07-01       Impact factor: 4.611

7.  Association of Mental Health Status With Perception of Nasal Function.

Authors:  Erika Strazdins; Yu Feng Nie; Raziqah Ramli; Tom Palesy; Jenna M Christensen; George Nicholas Marcells; Richard John Harvey
Journal:  JAMA Facial Plast Surg       Date:  2017-09-01       Impact factor: 4.611

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.